Denis Chem Lab Ltd. | Small-cap | Healthcare
₹95.75
1.25%
| Denis Chem Lab Stock Comparison:
Denis Chem Lab vs Sun PharmaceuticalDenis Chem Lab vs Divi's LaboratoriesDenis Chem Lab vs Suven Life SciencesDenis Chem Lab vs Sequent ScientificDenis Chem Lab vs Aarti DrugsDenis Chem Lab vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 432.8M
Gross Profit 187.1M 43.24%
Operating Income 32.0M 7.40%
Net Income 24.8M 5.72%
EPS (Diluted) ₹1.78

Balance Sheet Metrics

Total Assets 1.1B
Total Liabilities 271.7M
Shareholders Equity 851.0M
Debt to Equity 0.32

Cash Flow Metrics

Revenue & Profitability Trend

Denis Chem Lab Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.7B1.7B1.6B1.4B1.1B
Cost of Goods Sold i981.9M868.6M844.6M742.2M573.0M
Gross Profit i751.1M809.6M763.9M622.7M518.5M
Gross Margin % i43.3%48.2%47.5%45.6%47.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i174.1M-152.3M139.2M121.6M
Other Operating Expenses i248.1M453.4M445.8M190.4M155.7M
Total Operating Expenses i422.2M453.4M598.1M329.6M277.3M
Operating Income i103.1M142.9M109.6M116.6M76.5M
Operating Margin % i6.0%8.5%6.8%8.5%7.0%
Non-Operating Items
Interest Income i18.4M-4.7M1.9M1.8M
Interest Expense i741.0K5.4M6.4M5.0M12.0M
Other Non-Operating Income-----
Pre-tax Income i111.1M151.3M109.2M88.8M30.9M
Income Tax i30.4M39.8M30.6M26.2M8.2M
Effective Tax Rate % i27.3%26.3%28.0%29.5%26.7%
Net Income i80.8M111.6M78.6M62.6M22.6M
Net Margin % i4.7%6.6%4.9%4.6%2.1%
Key Metrics
EBITDA i190.2M226.2M193.7M173.4M134.1M
EPS (Basic) i₹5.82₹8.04₹5.66₹4.51₹1.63
EPS (Diluted) i₹5.82₹8.04₹5.66₹4.51₹1.63
Basic Shares Outstanding i1387666813875373138865721387666813876668
Diluted Shares Outstanding i1387666813875373138865721387666813876668

Income Statement Trend

Denis Chem Lab Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i8.5M11.9M24.8M13.0M15.7M
Short-term Investments i250.6M246.0M144.0M65.8M11.3M
Accounts Receivable i306.1M316.6M312.4M318.4M328.8M
Inventory i98.1M101.9M91.2M98.9M91.1M
Other Current Assets214.0K17.3M263.0K20.7M13.2M
Total Current Assets i706.4M693.7M592.4M533.2M485.5M
Non-Current Assets
Property, Plant & Equipment i39.9M374.4M37.9M37.7M37.7M
Goodwill i1.1M1.8M2.2M2.8M1.4M
Intangible Assets i1.1M1.8M2.2M2.8M1.4M
Long-term Investments-----
Other Non-Current Assets3.9M6.8M10.0M-5.3M
Total Non-Current Assets i416.3M399.8M402.1M430.7M437.1M
Total Assets i1.1B1.1B994.5M963.9M922.6M
Liabilities
Current Liabilities
Accounts Payable i212.4M214.1M182.8M197.0M156.7M
Short-term Debt i3.7M5.9M10.1M10.4M51.2M
Current Portion of Long-term Debt-----
Other Current Liabilities3.0M4.0M2.1M2.8M1.3M
Total Current Liabilities i261.7M272.0M240.8M253.1M251.0M
Non-Current Liabilities
Long-term Debt i4.5M4.5M9.2M21.8M35.0M
Deferred Tax Liabilities i1.1M9.6M19.4M18.6M8.3M
Other Non-Current Liabilities-1.0K---1.0K2
Total Non-Current Liabilities i10.0M17.9M31.1M46.3M56.6M
Total Liabilities i271.7M289.8M271.8M299.4M307.6M
Equity
Common Stock i138.8M138.8M138.8M138.8M138.8M
Retained Earnings i390.3M-261.9M203.8M154.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i851.0M803.7M722.6M664.5M615.0M
Key Metrics
Total Debt i8.2M10.5M19.3M32.2M86.2M
Working Capital i444.7M421.8M351.6M280.1M234.6M

Balance Sheet Composition

Denis Chem Lab Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i111.1M151.3M109.2M88.8M30.9M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i7.2M-27.6M19.6M1.1M10.3M
Operating Cash Flow i105.0M116.4M130.6M95.6M54.9M
Investing Activities
Capital Expenditures i-----
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i---69.2M1.1M1.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-34.7M-27.8M-20.8M-10.4M-
Debt Issuance i-----
Debt Repayment i---12.8M-54.0M-39.5M
Financing Cash Flow i-37.0M-31.9M-33.9M-105.2M-76.0M
Free Cash Flow i44.6M106.8M116.4M115.8M61.3M
Net Change in Cash i68.0M84.4M27.4M-8.5M-20.1M

Cash Flow Trend

Denis Chem Lab Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.50
Price to Book 1.56
Price to Sales 0.79
PEG Ratio 0.83

Profitability Ratios

Profit Margin 43.34%
Operating Margin 6.45%
Return on Equity 9.49%
Return on Assets 7.19%

Financial Health

Current Ratio 2.70
Debt to Equity 0.01

Per Share Data

EPS (TTM) ₹6.10
Book Value per Share ₹61.21
Revenue per Share ₹124.88

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
denischem1.4B15.501.569.49%43.34%0.01
Sun Pharmaceutical 4.0T37.735.4215.08%19.29%3.26
Divi's Laboratories 1.6T65.3710.1314.64%23.89%0.03
Suven Life Sciences 48.0B-28.3141.36-146.15%84.44%0.00
Sequent Scientific 48.1B166.336.612.84%1.85%62.47
Aarti Drugs 44.5B23.663.2612.28%7.80%44.92

Financial data is updated regularly. All figures are in the company's reporting currency.